SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-24-004389
Filing Date
2024-01-31
Accepted
2024-01-30 21:45:28
Documents
10

Document Format Files

Seq Description Document Type Size
1 form424b4.htm 424B4 2687452
2 form424b4_001.jpg GRAPHIC 3980
3 form424b4_002.jpg GRAPHIC 18822
4 form424b4_003.jpg GRAPHIC 18822
5 form424b4_004.jpg GRAPHIC 6241
6 form424b4_005.jpg GRAPHIC 7165
7 form424b4_006.jpg GRAPHIC 18524
8 form424b4_007.jpg GRAPHIC 15466
9 form424b4_008.jpg GRAPHIC 11579
10 form424b4_009.jpg GRAPHIC 12097
  Complete submission text file 0001493152-24-004389.txt   2844774
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-275361 | Film No.: 24580453
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)